Statistics for Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials

Total visits

views
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials 175

Total visits per month

views
June 2024 1
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
Sayar_2019_combination.pdf 332

Top country views

views
United States 133
Ukraine 6
Germany 5
Sweden 5
Russia 4
France 3
Canada 2
Switzerland 1
China 1
United Kingdom 1
Malaysia 1

Top city views

views
Wilmington 46
Fairfield 20
Houston 14
White Plains 7
Cambridge 6
Jacksonville 6
Kiev 5
Kiez 5
Stockholm 5
Ann Arbor 2
Paris 2
San Francisco 2
Seattle 2
Toronto 2
Baltimore 1
Beijing 1
Brooklyn 1
Bryansk 1
Carmel 1
Cointrin 1
Kharkov 1
Mesa 1
Nanterre 1
Northville 1
Philadelphia 1
Redwood City 1
Saint Petersburg 1
Seremban 1
Zheleznogorsk 1